| Transmembrane peptides as unique tools to demonstrate the in vivo action of a cross-class GPCR heterocomplex LTO Lee, SYL Ng, JYS Chu, R Sekar, KG Harikumar, LJ Miller, BKC Chow The FASEB Journal 28 (6), 2632, 2014 | 47 | 2014 |
| Glucagon’s metabolic action in health and disease A Zeigerer, R Sekar, M Kleinert, S Nason, KM Habegger, TD Müller Comprehensive Physiology 11 (2), 1759, 2021 | 40 | 2021 |
| Secretin receptor‐knockout mice are resistant to high‐fat diet‐induced obesity and exhibit impaired intestinal lipid absorption R Sekar, BKC Chow The FASEB Journal 28 (8), 3494-3505, 2014 | 38 | 2014 |
| A macrophage-hepatocyte glucocorticoid receptor axis coordinates fasting ketogenesis A Loft, SF Schmidt, G Caratti, U Stifel, J Havelund, R Sekar, Y Kwon, ... Cell Metabolism 34 (3), 473-486. e9, 2022 | 36 | 2022 |
| Central control of feeding behavior by the secretin, PACAP, and glucagon family of peptides R Sekar, L Wang, BKC Chow Frontiers in endocrinology 8, 240205, 2017 | 35 | 2017 |
| Lipolytic actions of secretin in mouse adipocytes [S] R Sekar, BKC Chow Journal of lipid research 55 (2), 190-200, 2014 | 29 | 2014 |
| Vagal afferent mediates the anorectic effect of peripheral secretin JYS Chu, CYY Cheng, R Sekar, BKC Chow PloS one 8 (5), e64859, 2013 | 27 | 2013 |
| Hepatic Rab24 controls blood glucose homeostasis via improving mitochondrial plasticity S Seitz, Y Kwon, G Hartleben, J Jülg, R Sekar, N Krahmer, B Najafi, A Loft, ... Nature Metabolism 1 (10), 1009-1026, 2019 | 26 | 2019 |
| Pharmacological actions of glucagon-like peptide-1, gastric inhibitory polypeptide, and glucagon R Sekar, K Singh, AWR Arokiaraj, BKC Chow International review of cell and molecular biology 326, 279-341, 2016 | 26 | 2016 |
| Metabolic effects of secretin R Sekar, BKC Chow General and comparative endocrinology 181, 18-24, 2013 | 23 | 2013 |
| Glycyrrhizic acid reduces heart rate and blood pressure by a dual mechanism K Singh, AM Zaw, R Sekar, A Palak, AA Allam, J Ajarem, BKC Chow Molecules 21 (10), 1291, 2016 | 15 | 2016 |
| Loss of secretin results in systemic and pulmonary hypertension with cardiopulmonary pathologies in mice AM Zaw, R Sekar, SOK Mak, HKW Law, BKC Chow Scientific Reports 9 (1), 14211, 2019 | 9 | 2019 |
| Geno protective and anti-apoptotic effect of green tea against perinatal lipopolysaccharide-exposure induced liver toxicity in rat newborns AA Allam, SA Gabr, J Ajarem, AH Alghadir, R Sekar, BKC Chow African Journal of Traditional, Complementary and Alternative Medicines 14 …, 2017 | 9 | 2017 |
| Role of secretin peptide family and their receptors in the hypothalamic control of energy homeostasis R Sekar, BKC Chow Hormone and metabolic research 45 (13), 945-954, 2013 | 9 | 2013 |
| Hepatocyte-specific activity of TSC22D4 triggers progressive NAFLD by impairing mitochondrial function G Wolff, M Sakurai, A Mhamane, M Troullinaki, A Maida, IK Deligiannis, ... Molecular Metabolism 60, 101487, 2022 | 6 | 2022 |
| Vps37a regulates hepatic glucose production by controlling glucagon receptor localization to endosomes R Sekar, K Motzler, Y Kwon, A Novikoff, J Jülg, B Najafi, S Wang, ... Cell metabolism 34 (11), 1824-1842. e9, 2022 | 5 | 2022 |
| Metabolism in nonalcoholic fatty liver disease SM Najjar, HE Ghadieh, R Sekar, R Carraro, LG Noriega, AMA Paes Frontiers in Physiology 14, 1275319, 2023 | | 2023 |
| Novel endosomal trafficking adaptor for the regulation of NAFLD to NASH progression K Motzler, K Nalbach, R Sekar, A Alfaro, MH de Angelis, M Blüher, ... Journal of Hepatology 77, S703-S704, 2022 | | 2022 |
| Liver-specific Tsg101 depletion causes apoptosis, cell death and liver failure S Wang, R Sekar, J Cendrowski, A Ghallab, K Motzler, Y Kwon, S Seitz, ... Journal of Hepatology 77, S606-S607, 2022 | | 2022 |
| Novel function for endosomal trafficking adaptors in hepatic metabolic disease K Nalbach, R Sekar, AJ Alfaro, MH de Angelis, S Herzig, M Roden, ... Zeitschrift für Gastroenterologie 60 (01), P 3.27, 2022 | | 2022 |
